News

The drug is designed to treat active rheumatoid arthritis and comes under a category of disease modifying anti-rheumatic drugs (DMARDS). The clinical studies demonstrate that Iremod can relieve

Baxa develops pharmacy technology including ExactaMix compounder, devices which automate multi-ingredient nutritional solution compounding and the DoseEdge Pharmacy Workflow Manager, an integrated system for managing IV and oral

The study is a dose-escalation, open-label, multiple-dose trial to evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.

Revlimid is indicated as a treatment for multiple myeloma and anemia due to myelodysplastic syndrome linked with a deletion in the long arm of the fifth chromosome. In

Under the deal, the product will be marketed under Lodrane brand name by Hi-Tech’s branded sales and marketing company, ECR. Hi-Tech specializes in difficult to manufacture liquid and

The grant will support continued preclinical research on microRNA targeting in cardiovascular disease and help to establish a novel model system of chronic heart failure. The research aims

The company expects to conclude the Phase II trials in early next year. Lightlake intends to conduct Phase III trial at Imperial College London and other international institutions.

The results of the studies showed that the company’s RSV vaccine induces protective immunity in mice without eliciting the enhanced respiratory disease that has caused other RSV vaccine

The trial evaluated patients with locally advanced or metastatic breast cancer who had received one prior chemotherapy regimen were treated with weekly bavituximab and docetaxel. In a separate